Allopurinol Tablet
Product Images NDC 71610-676

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 71610-676). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 100 mg (71610 0676 53)

Bottle Label 100 mg (71610 0676 53)
Allopurinol and Purinol are two drugs that are commonly used for the treatment of gout and certain types of kidney stones. Allopurinol is the United States Pharmacopeia (USP) standard name for this medication, while Purinol is also listed as a USP name for allopurinol. Both drugs are classified as xanthine oxidase inhibitors and work by reducing the production of uric acid, which can lead to the formation of gout and kidney stones.*
FDA Label Image

Allopurinol-ros (Allopurinol Ros)

FDA Label Image

Allopurinol-struct (Allopurinol Struct)

FDA Label Image

Aphena Pharma Solutions (TN)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.